Segall Bryant & Hamill LLC Sells 18,134 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Segall Bryant & Hamill LLC lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 51.1% in the third quarter, HoldingsChannel.com reports. The fund owned 17,379 shares of the company’s stock after selling 18,134 shares during the period. Segall Bryant & Hamill LLC’s holdings in Addus HomeCare were worth $2,312,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. ProShare Advisors LLC lifted its position in Addus HomeCare by 7.3% during the first quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock valued at $327,000 after purchasing an additional 214 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after acquiring an additional 19,027 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in Addus HomeCare by 4.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 16,837 shares of the company’s stock worth $1,738,000 after acquiring an additional 761 shares in the last quarter. EntryPoint Capital LLC purchased a new stake in Addus HomeCare during the first quarter valued at about $44,000. Finally, Quadrature Capital Ltd bought a new stake in Addus HomeCare during the first quarter worth about $1,557,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,917 shares of company stock valued at $3,050,082. Company insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. TD Cowen raised their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Stephens increased their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $124.32 on Friday. The stock’s 50-day moving average is $128.25 and its 200 day moving average is $123.17. The company has a market cap of $2.25 billion, a PE ratio of 28.45, a P/E/G ratio of 2.11 and a beta of 1.04. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.03 earnings per share. Analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.